Biscayne NeuroTherapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
January 27, 2017
Vertical
Biotechnology
Funding Amount
$3,000,000
Company Info
Founders
Stephen Collins
Market
Central Nervous System Disorders
Location
Miami, FL, USA
Coinvestors
GF Securities, Mesa Verde Venture Partners, Quark Venture
Company Description

Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.